These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 24726807)

  • 21. Novel-smoothened inhibitors for therapeutic targeting of naïve and drug-resistant hedgehog pathway-driven cancers.
    Li QR; Zhao H; Zhang XS; Lang H; Yu K
    Acta Pharmacol Sin; 2019 Feb; 40(2):257-267. PubMed ID: 29777201
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hedgehog pathway inhibition in chondrosarcoma using the smoothened inhibitor IPI-926 directly inhibits sarcoma cell growth.
    Campbell VT; Nadesan P; Ali SA; Wang CY; Whetstone H; Poon R; Wei Q; Keilty J; Proctor J; Wang LW; Apte SS; McGovern K; Alman BA; Wunder JS
    Mol Cancer Ther; 2014 May; 13(5):1259-69. PubMed ID: 24634412
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Smoothened goes molecular: new pieces in the hedgehog signaling puzzle.
    McCabe JM; Leahy DJ
    J Biol Chem; 2015 Feb; 290(6):3500-7. PubMed ID: 25519909
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Discovery of [1,2,4]triazolo[4,3-a]pyridines as potent Smoothened inhibitors targeting the Hedgehog pathway with improved antitumor activity in vivo.
    Tian N; Wu H; Zhang H; Yang D; Lv L; Yang Z; Zhang T; Quan D; Zhou L; Xie Y; Xu Y; Wei N; Zhang J; Chen M; Schmitz JC; Tian Y; Wu S
    Bioorg Med Chem; 2020 Aug; 28(16):115584. PubMed ID: 32690258
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A New Smoothened Antagonist Bearing the Purine Scaffold Shows Antitumour Activity In Vitro and In Vivo.
    Zárate AM; Espinosa-Bustos C; Guerrero S; Fierro A; Oyarzún-Ampuero F; Quest AFG; Di Marcotullio L; Loricchio E; Caimano M; Calcaterra A; González-Quiroz M; Aguirre A; Meléndez J; Salas CO
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445078
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeting the hedgehog signal transduction pathway at the level of GLI inhibits neuroblastoma cell growth in vitro and in vivo.
    Wickström M; Dyberg C; Shimokawa T; Milosevic J; Baryawno N; Fuskevåg OM; Larsson R; Kogner P; Zaphiropoulos PG; Johnsen JI
    Int J Cancer; 2013 Apr; 132(7):1516-24. PubMed ID: 22949014
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular pathways: the hedgehog signaling pathway in cancer.
    McMillan R; Matsui W
    Clin Cancer Res; 2012 Sep; 18(18):4883-8. PubMed ID: 22718857
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of Hedgehog-dependent tumors and cancer stem cells by a newly identified naturally occurring chemotype.
    Infante P; Alfonsi R; Ingallina C; Quaglio D; Ghirga F; D'Acquarica I; Bernardi F; Di Magno L; Canettieri G; Screpanti I; Gulino A; Botta B; Mori M; Di Marcotullio L
    Cell Death Dis; 2016 Sep; 7(9):e2376. PubMed ID: 27899820
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeting Hedgehog signaling and understanding refractory response to treatment with Hedgehog pathway inhibitors.
    Queiroz KC; Spek CA; Peppelenbosch MP
    Drug Resist Updat; 2012 Aug; 15(4):211-22. PubMed ID: 22910179
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Structure of the Smoothened receptor].
    Ruat M; Hoch L; Faure H; Rognan D
    Med Sci (Paris); 2013 Oct; 29(10):855-60. PubMed ID: 24148123
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Role of Smoothened in Cancer.
    Jeng KS; Sheen IS; Leu CM; Tseng PH; Chang CF
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32962123
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synergistic inhibition of the Hedgehog pathway by newly designed Smo and Gli antagonists bearing the isoflavone scaffold.
    Berardozzi S; Bernardi F; Infante P; Ingallina C; Toscano S; De Paolis E; Alfonsi R; Caimano M; Botta B; Mori M; Di Marcotullio L; Ghirga F
    Eur J Med Chem; 2018 Aug; 156():554-562. PubMed ID: 30025349
    [TBL] [Abstract][Full Text] [Related]  

  • 33. State of the art of Smo antagonists for cancer therapy: advances in the target receptor and new ligand structures.
    Espinosa-Bustos C; Mella J; Soto-Delgado J; Salas CO
    Future Med Chem; 2019 Mar; 11(6):617-638. PubMed ID: 30912670
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oxysterol binding to the extracellular domain of Smoothened in Hedgehog signaling.
    Nedelcu D; Liu J; Xu Y; Jao C; Salic A
    Nat Chem Biol; 2013 Sep; 9(9):557-64. PubMed ID: 23831757
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel synthetic smoothened antagonist transiently inhibits pancreatic adenocarcinoma xenografts in a mouse model.
    Strand MF; Wilson SR; Dembinski JL; Holsworth DD; Khvat A; Okun I; Petersen D; Krauss S
    PLoS One; 2011; 6(6):e19904. PubMed ID: 21698280
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hedgehog inhibition as an anti-cancer strategy.
    Raju GP; Pham D
    Vitam Horm; 2012; 88():507-22. PubMed ID: 22391319
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hedgehog pathway inhibitors: a patent review (2009--present).
    Hadden MK
    Expert Opin Ther Pat; 2013 Mar; 23(3):345-61. PubMed ID: 23294277
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Current trends in Hedgehog signaling pathway inhibition by small molecules.
    Ghirga F; Mori M; Infante P
    Bioorg Med Chem Lett; 2018 Oct; 28(19):3131-3140. PubMed ID: 30177379
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acylthiourea, acylurea, and acylguanidine derivatives with potent hedgehog inhibiting activity.
    Solinas A; Faure H; Roudaut H; Traiffort E; Schoenfelder A; Mann A; Manetti F; Taddei M; Ruat M
    J Med Chem; 2012 Feb; 55(4):1559-71. PubMed ID: 22268551
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibiting Hedgehog: An Update on Pharmacological Compounds and Targeting Strategies.
    Galperin I; Dempwolff L; Diederich WE; Lauth M
    J Med Chem; 2019 Sep; 62(18):8392-8411. PubMed ID: 30986059
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.